(19)

(11)

EP 4 577 875 A2

(12)

(88) Date of publication A3: 18.04.2024 (43) Date of publication: 02.07.2025 Bulletin 2025/27 (21) Application number: 23858002.1 (22) Date of filing: 22.08.2023

(51) International Patent Classification (IPC):  G03F 7/30(2006.01) B05B 1/34(2006.01) G03F 7/00(2006.01) B05B 12/00(2018.01) (52) Cooperative Patent Classification (CPC): G03F 7/322; G03F 7/3092; B05B 1/202; B05B 1/3402; B05B 1/3006; B05B 13/0221; B05B 14/20; B05B 9/0403 (86) International application number: PCT/US2023/030852 (87) International publication number: WO 2024/044206 (29.02.2024 Gazette 2024/09)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 23.08.2022 US 202217893782 (71) Applicant: Miraclon Corporation Oakdale MN 55128 (US)	(72) Inventors: AVIEL, David Oakdale, MN 55128 (US) MELLEMA, Fredrick, Charles Oakdale, MN 55128 (US) WILLIAMS, Andrew, R. Oakdale, MN 55128 (US) (74) Representative: Keltie LLP  No. 1 London Bridge London SE1 9BA London SE1 9BA (GB)